Keywords: β-گلوکوکربروزیداز; GD; Gaucher disease; GCase; β-glucocerebrosidase; GC; β-glucosylceramide; PD; Parkinson disease; ERT; enzyme-replacement therapy; GBA; glucocerebrosidase gene; GBA-EMI; GBA expected mutation impact; ER; endoplasm reticulum; DCs; dendritic-cells; NKT; na
مقالات ISI β-گلوکوکربروزیداز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: β-گلوکوکربروزیداز; aCEase; acid-ceramidase; β-GlcCer'ase; β-glucocerebrosidase; EDTA; ethylenediaminetetraacetic acid; FLG; filaggrin; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; IL; interleukin; IVL; involucrin; LOR; loricrin; mRNA; messenger RNA; NHKs; normal hum
Keywords: β-گلوکوکربروزیداز; Progranulin; β-Glucocerebrosidase; Gaucher disease; Lysosomal storage diseases;
Keywords: β-گلوکوکربروزیداز; BMP; bis(monoacylglycero)phosphate; Cer; ceramide; DHC; dihexosylceramide; GalCer; galactosylceramide; GCase; β-glucocerebrosidase; GBA1; β-glucocerebrosidase gene; GlcCer; glucosylceramide; GlcSph; glucosylsphingosine; PC; phosphatidylcholine; PE; phos
Keywords: β-گلوکوکربروزیداز; α-synuclein; β-glucocerebrosidase; Gaucher disease; Parkinson disease;
Keywords: β-گلوکوکربروزیداز; AA; arachidonic acid; ADAPS; alkyl-dihydroxyacetonephosphate synthase; Cer; ceramide; DHA; docosahexaenoic acid; DHAPAT; dihydroxyacetonephosphate acyltransferase; DMA; dimethylacetal; GBA; β-glucocerebrosidase; GD; Gaucher disease; GlcCer; glucosylceram
Borage oil restores acidic skin pH by up-regulating the activity or expression of filaggrin and enzymes involved in epidermal lactate, free fatty acid, and acidic free amino acid metabolism in essential fatty acid-deficient Guinea pigs
Keywords: β-گلوکوکربروزیداز; Borage oil; Skin pH; Lactate; Free fatty acids; Acidic free amino acids; Guinea pig; BO; borage oil; EFA; essential fatty acid; EFAD; essential fatty acid deficiency; FFA; free fatty acid; FAA; free amino acid; GCase; β-glucocerebrosidase; GLA; γ-linole
Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials
Keywords: β-گلوکوکربروزیداز; β-GC; β-glucocerebrosidase; CCL18; chemokine (C-C motif) ligand 18; ERT; enzyme replacement therapy; GD; Gaucher disease; lyso-Gb1; glucosylsphingosine; MN; multiples of normal; Gaucher disease; Glucosylsphingosine; Lyso-Gb1; Velaglucerase alfa; Enzyme
Combined Benefits of a PAR2 Inhibitor and Stratum Corneum Acidification for Murine Atopic Dermatitis
Keywords: β-گلوکوکربروزیداز; AD; atopic dermatitis; β-GlcCer'ase; β-glucocerebrosidase; IL; interleukin; LBA; lactobionic acid; Ox-AD; oxazolone-induced atopic-dermatitis-like dermatitis; PAR2; protease-activated receptor-2; SC; stratum corneum; TEWL; transepidermal water loss; T
Development and application to clinical practice of a validated HPLC method for the analysis of β-glucocerebrosidase in Gaucher disease
Keywords: β-گلوکوکربروزیداز; GD; Gaucher disease; GBA; β-glucocerebrosidase; GlcCer; glucocerebroside; FACS; fluorescence-activated cell sorter; PNP-Glc; 4-nitrophenyl-β-d-glucopyranoside; PNP; p-nitrophenol; ERT; enzyme replacement therapy; IMG; imiglucerase; EMA; European Medicin
β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease
Keywords: β-گلوکوکربروزیداز; GD; Gaucher disease; GBA; β-Glucocerebrosidase; PD; Parkinson's disease; EOPD; Early onset Parkinson's disease; β-Glucocerebrosidase gene mutations; Parkinson's disease;
Synthesis of new β-1-C-alkylated imino-l-iditols: A comparative study of their activity as β-glucocerebrosidase inhibitors
Keywords: β-گلوکوکربروزیداز; Iminosugar C-glycosides; l-ido Series; β-Glucocerebrosidase; Lysosomal diseases;
Use of fluorescent substrates for characterization of Gaucher disease mutations
Keywords: β-گلوکوکربروزیداز; Bodipy-12-GC; Bodipy dodecanoyl β glucosylceramide; DMEM; Dulbecco's modified Eagle's medium; FCS; fetal calf serum; GCase; glucocerebrosidase; LR-12-GC; lissamine rhodamine dodecanoyl β glucosylceramide; LR-0-PAP; lissamine rhodamine-p-aminophenyl β-g
Le diagnostic biochimique de la maladie de Gaucher
Keywords: β-گلوکوکربروزیداز; Sphingolipidoses; Maladies de surcharge lysosomales; Maladie de Gaucher; Hydrolases acides; β-glucocérébrosidase; Dosage intraleucocytaire; Fluorimétrie; Enzymothérapie substitutive; Chitotriosidase; Sphingolipidosis; Lysosomal storage disorder; Gauc